ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01008150
Brief Title: Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

First Submitted : November 3, 2009
First Submitted that Met QC Criteria : November 4, 2009
First Posted : November 5, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : July 31, 2018
Last Update Posted : August 1, 2018